Gemmer Asset Management LLC Bausch Health Companies Inc. Transaction History

Gemmer Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$7.06 - $23.63 $458 - $1,535	-65 Closed	0 $0
Q3 2020 Oct 21, 2020	BUY	$14.88 - $20.13 $104 - $140	7 Added 12.07%	65 $1,000
Q2 2020 Jul 31, 2020	SELL	$13.31 - $20.51 $638 - $984	-48 Reduced 45.28%	58 $1,000
Q1 2020 May 01, 2020	SELL	$12.98 - $30.25 $1,220 - $2,843	-94 Reduced 47.0%	106 $1,000
Q4 2019 Jan 17, 2020	BUY	$18.89 - $31.89 $3,778 - $6,378	200 New	200 $6,000
Q2 2019 Jul 18, 2019	SELL	$20.52 - $26.45 $902 - $1,163	-44 Closed	0 $0
Q1 2019 Apr 17, 2019	BUY	$20.23 - $26.29 $890 - $1,156	44 New	44 $1,000
Q4 2018 Jan 18, 2019	SELL	$17.64 - $28.32 $864 - $1,387	-49 Closed	0 $0
Q3 2018 Oct 12, 2018	BUY	$20.64 - $25.67 $1,011 - $1,257	49 New	49 $1,000

275

279M

5.68M

17.4M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.01B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gemmer Asset Management LLC with notifications on news.